Is a complete BVMF/E2XE34 research report available?

No complete published report is available for bvmf/E2XE34 (BVMF/E2XE34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/E2XE34 (BVMF/E2XE34)

Brazil Stock Exchange: BVMF/E2XE34 · BRL

R$143

+0.00 (0.0%)· Recorded snapshot

Market cap	88.2B
Revenue (ttm)	12.6B
Net income (ttm)	4.5B
EPS (ttm)	R$8.61
P/E (trailing)	16.7x
P/E (forward)	16.2x
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.6B
Net income (ttm): 4.5B
EPS (ttm): R$8.61
P/E (trailing): 16.7x
P/E (forward): 16.2x
Market cap: 88.2B

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	1,077
Employees change	-70
Employees growth	-6.1%
Enterprise value	BRL 81.7B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	1994
Industry	Biotechnology
Is primary listing	No
ISIN number	BRE2XEBDR001
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	BRL 88.2B
Next earnings date	2026-10-29
Price	BRL 143.40
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-05
Symbol	bvmf/E2XE34
Website	https://www.exelixis.com

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-10-29

Employees

1,077

Employees change

-70

Employees growth

-6.1%

Enterprise value

BRL 81.7B

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-10-10

Fiscal year end

December

Founded

1994

Industry

Biotechnology

Is primary listing

ISIN number

BRE2XEBDR001

Last earnings date

2026-10-29

Last refreshed

2026-10-29

Market cap

BRL 88.2B

Next earnings date

2026-10-29

Price

BRL 143.40

Price currency

BRL

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-05

Symbol

bvmf/E2XE34

Website

https://www.exelixis.com

Metric	Value
Average P/E ratio (10Y)	60.9x
Average P/E ratio (3Y)	24.67x
Average P/E ratio (5Y)	26.7x
Earnings yield	6%
EV/Earnings	18.32x
EV/EBIT	15.33x
EV/EBITDA	14.48x
EV/FCF	13.45x
EV/Sales	6.24x
FCF / EV yield	7.44%
FCF yield	6.88%
Forward P/E	16.2x
Graham number	50.3069
Graham upside	-64.92%
Lynch fair value	BRL 181.15
Lynch upside	26.32%
P/(FCF - SBC) ratio	16.07x
P/(OCF - SBC) ratio	15.91x
P/B ratio	9.24x
P/E ratio	16.65x
P/FCF ratio	14.53x
P/OCF ratio	14.39x
P/S ratio	6.99x
Price / tangible book value	9.57x
Price/EBITDA ratio	16.69x
Sector forward P/E	11.05x
Sector P/E	41.08x

Metric

Value

Average P/E ratio (10Y)

60.9x

Average P/E ratio (3Y)

24.67x

Average P/E ratio (5Y)

26.7x

Earnings yield

EV/Earnings

18.32x

EV/EBIT

15.33x

EV/EBITDA

14.48x

EV/FCF

13.45x

EV/Sales

6.24x

FCF / EV yield

7.44%

FCF yield

6.88%

Forward P/E

16.2x

Graham number

50.3069

Graham upside

-64.92%

Lynch fair value

BRL 181.15

Lynch upside

26.32%

P/(FCF - SBC) ratio

16.07x

P/(OCF - SBC) ratio

15.91x

P/B ratio

9.24x

P/E ratio

16.65x

P/FCF ratio

14.53x

P/OCF ratio

14.39x

P/S ratio

6.99x

Price / tangible book value

9.57x

Price/EBITDA ratio

16.69x

Sector forward P/E

11.05x

Sector P/E

41.08x

Metric	Value
EBIT margin	40.72%
EBITDA margin	41.89%
Effective tax rate	16.89%
FCF margin	46.13%
Gross margin	96.48%
Operating margin	40.72%
Pretax margin	42.51%
Profit margin	35.33%
Profit per employee	BRL 4.1M
Profitable quarters	14
Profitable years	9
Revenue per employee	BRL 11.7M
ROA	23.97%
ROA (5Y)	9.89%
ROCE	46.52%
ROE	44.39%
ROE (5Y)	17.29%
ROIC	66%
ROIC (5Y)	29.34%
SBC / revenue	4.62%
Tax / revenue	7.18%

Metric

Value

EBIT margin

40.72%

EBITDA margin

41.89%

Effective tax rate

16.89%

FCF margin

46.13%

Gross margin

96.48%

Operating margin

40.72%

Pretax margin

42.51%

Profit margin

35.33%

Profit per employee

BRL 4.1M

Profitable quarters

Profitable years

Revenue per employee

BRL 11.7M

ROA

23.97%

ROA (5Y)

9.89%

ROCE

46.52%

ROE

44.39%

ROE (5Y)

17.29%

ROIC

66%

ROIC (5Y)

29.34%

SBC / revenue

4.62%

Tax / revenue

7.18%

Metric	Value
EPS growth	53.41%
EPS growth (Q)	26.15%
EPS growth (QoQ)	3.8%
EPS growth 3Y	85.25%
EPS growth 5Y	61.2%
EPS growth quarters	4
EPS growth years	3
FCF growth	55.49%
FCF growth (Q)	551.99%
FCF growth (QoQ)	20.21%
FCF growth 3Y	48.72%
FCF growth 5Y	39.99%
Gross profit growth	9.11%
Gross profit growth (Q)	10.8%
Gross profit growth 3Y	12.49%
Gross profit growth 5Y	16.17%
Net income growth	42.89%
Net income growth (Q)	14.72%
Net income growth (QoQ)	0.75%
Net income growth 3Y	73.69%
Net income growth 5Y	55.7%
Net income growth quarters	4
Net income growth years	3
OCF growth	53.29%
OCF growth (Q)	528.13%
OCF growth (QoQ)	22.19%
OCF growth 10Y	34.43%
OCF growth 3Y	44.88%
OCF growth 5Y	34.16%
Operating income growth	31.96%
Operating income growth (Q)	16.31%
Operating income growth 3Y	91.52%
Operating income growth 5Y	58.2%
Revenue growth	9.23%
Revenue growth (Q)	10.63%
Revenue growth (QoQ)	2.93%
Revenue growth 10Y	42.32%
Revenue growth 3Y	12.42%
Revenue growth 5Y	16.06%
Revenue growth quarters	4
Revenue growth years	11

Metric

Value

EPS growth

53.41%

EPS growth (Q)

26.15%

EPS growth (QoQ)

3.8%

EPS growth 3Y

85.25%

EPS growth 5Y

61.2%

EPS growth quarters

EPS growth years

FCF growth

55.49%

FCF growth (Q)

551.99%

FCF growth (QoQ)

20.21%

FCF growth 3Y

48.72%

FCF growth 5Y

39.99%

Gross profit growth

9.11%

Gross profit growth (Q)

10.8%

Gross profit growth 3Y

12.49%

Gross profit growth 5Y

16.17%

Net income growth

42.89%

Net income growth (Q)

14.72%

Net income growth (QoQ)

0.75%

Net income growth 3Y

73.69%

Net income growth 5Y

55.7%

Net income growth quarters

Net income growth years

OCF growth

53.29%

OCF growth (Q)

528.13%

OCF growth (QoQ)

22.19%

OCF growth 10Y

34.43%

OCF growth 3Y

44.88%

OCF growth 5Y

34.16%

Operating income growth

31.96%

Operating income growth (Q)

16.31%

Operating income growth 3Y

91.52%

Operating income growth 5Y

58.2%

Revenue growth

9.23%

Revenue growth (Q)

10.63%

Revenue growth (QoQ)

2.93%

Revenue growth 10Y

42.32%

Revenue growth 3Y

12.42%

Revenue growth 5Y

16.06%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	BRL -56.8M
Depreciation and amortization	BRL 153M
EBIT	BRL 5.1B
EBITDA	BRL 5.3B
EPS	BRL 8.61
Financing cash flow	BRL -6B
Free cash flow	BRL 6.1B
Free cash flow minus SBC	BRL 5.5B
Gross profit	BRL 12.2B
Income taxes	BRL 905.8M
Investing cash flow	BRL 481.8M
Net cash flow	BRL 606.2M
Net income	BRL 4.5B
Operating cash flow minus SBC	BRL 5.5B
Operating income	BRL 5.1B
Revenue	BRL 12.6B
Stock-based compensation	BRL 583.3M

Metric

Value

Capital expenditures

BRL -56.8M

Depreciation and amortization

BRL 153M

EBIT

BRL 5.1B

EBITDA

BRL 5.3B

EPS

BRL 8.61

Financing cash flow

BRL -6B

Free cash flow

BRL 6.1B

Free cash flow minus SBC

BRL 5.5B

Gross profit

BRL 12.2B

Income taxes

BRL 905.8M

Investing cash flow

BRL 481.8M

Net cash flow

BRL 606.2M

Net income

BRL 4.5B

Operating cash flow minus SBC

BRL 5.5B

Operating income

BRL 5.1B

Revenue

BRL 12.6B

Stock-based compensation

BRL 583.3M

Metric	Value
Altman Z-Score	13.09
Book value per share	BRL 38.38
Debt / EBITDA	0.16
Debt / equity	0.09
Debt / FCF	0.14
Goodwill	BRL 344.3M
Long-term assets	BRL 6.2B
Long-term liabilities	BRL 1.4B
Net cash (debt)	BRL 6.3B
Net cash / market cap	7.15%
Net cash growth	1.03%
Net debt / EBITDA	-1.19
Net debt / equity	-0.66
Net debt / FCF	-1.04
Piotroski F-Score	5
Property, plant and equipment	BRL 1.6B
Shareholders' equity	BRL 9.6B
Tangible book value	BRL 9.2B
Tangible book value per share	BRL 37.05
Total assets	BRL 12.9B
Total cash	BRL 4.3B
Total debt	BRL 859.6M
Total liabilities	BRL 3.4B

Metric

Value

Altman Z-Score

13.09

Book value per share

BRL 38.38

Debt / EBITDA

0.16

Debt / equity

0.09

Debt / FCF

0.14

Goodwill

BRL 344.3M

Long-term assets

BRL 6.2B

Long-term liabilities

BRL 1.4B

Net cash (debt)

BRL 6.3B

Net cash / market cap

7.15%

Net cash growth

1.03%

Net debt / EBITDA

-1.19

Net debt / equity

-0.66

Net debt / FCF

-1.04

Piotroski F-Score

Property, plant and equipment

BRL 1.6B

Shareholders' equity

BRL 9.6B

Tangible book value

BRL 9.2B

Tangible book value per share

BRL 37.05

Total assets

BRL 12.9B

Total cash

BRL 4.3B

Total debt

BRL 859.6M

Total liabilities

BRL 3.4B

Metric	Value
Asset turnover	0.94
Current assets	BRL 6.8B
Current liabilities	BRL 2B
Current ratio	3.46
Inventory turnover	3.28
Net working capital	BRL 256.5M
Quick ratio	3.24
Working capital	BRL 4.6B
Working capital turnover	14.56

Metric

Value

Asset turnover

0.94

Current assets

BRL 6.8B

Current liabilities

BRL 2B

Current ratio

3.46

Inventory turnover

3.28

Net working capital

BRL 256.5M

Quick ratio

3.24

Working capital

BRL 4.6B

Working capital turnover

14.56

Metric	Value
Buyback yield / dilution	6.54%
Shareholder yield	6.54%

Metric

Value

Buyback yield / dilution

6.54%

Shareholder yield

6.54%

Metric	Value
150-day SMA	BRL 109.34
1D price change	0%
1M price change	4.37%
1M total return	4.37%
1W price change	-0%
1W total return	-0%
1Y price change	33.4%
1Y return CAGR	33.42%
1Y total return	33.4%
20-day SMA	BRL 124.12
200-day SMA	BRL 95.32
3M price change	6.68%
3M total return	6.68%
50-day SMA	BRL 115.23
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 143.40
52-week high date	2026-10-05
52-week low	BRL 98.24
52-week low date	2025-11-03
6M price change	31.42%
6M total return	31.42%
All-time high	BRL 143.40
All-time high date	2026-10-05
All-time low	BRL 40.00
All-time low date	2022-10-10
Average true range (ATR)	BRL 4.41
Average volume	108.5
Change from 52-week high	-0%
Change from 52-week low	45.97%
Change from all-time high	-0%
Change from all-time low	258.5%
Change from open	0%
Day's gap	0%
High price	BRL 143.40
Low price	BRL 143.40
Monthly RSI	69.6
Open price	BRL 143.40
Previous close	BRL 143.40
Price vs 150-day SMA	31.15%
Price vs 20-day SMA	15.53%
Price vs 200-day SMA	50.44%
Price vs 50-day SMA	24.45%
Relative volume	0.01
RSI	66.55
Sharpe ratio	1.89
Sortino ratio	3.39
Volume	0
Weekly RSI	67.35
YTD price change	19.38%
YTD total return	19.38%

Metric

Value

150-day SMA

BRL 109.34

1D price change

1M price change

4.37%

1M total return

4.37%

1W price change

-0%

1W total return

-0%

1Y price change

33.4%

1Y return CAGR

33.42%

1Y total return

33.4%

20-day SMA

BRL 124.12

200-day SMA

BRL 95.32

3M price change

6.68%

3M total return

6.68%

50-day SMA

BRL 115.23

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 143.40

52-week high date

2026-10-05

52-week low

BRL 98.24

52-week low date

2025-11-03

6M price change

31.42%

6M total return

31.42%

All-time high

BRL 143.40

All-time high date

2026-10-05

All-time low

BRL 40.00

All-time low date

2022-10-10

Average true range (ATR)

BRL 4.41

Average volume

108.5

Change from 52-week high

-0%

Change from 52-week low

45.97%

Change from all-time high

-0%

Change from all-time low

258.5%

Change from open

Day's gap

High price

BRL 143.40

Low price

BRL 143.40

Monthly RSI

69.6

Open price

BRL 143.40

Previous close

BRL 143.40

Price vs 150-day SMA

31.15%

Price vs 20-day SMA

15.53%

Price vs 200-day SMA

50.44%

Price vs 50-day SMA

24.45%

Relative volume

0.01

RSI

66.55

Sharpe ratio

1.89

Sortino ratio

3.39

Volume

Weekly RSI

67.35

YTD price change

19.38%

YTD total return

19.38%

Metric	Value
Float	213.6M
Shares change (QoQ)	-2.86%
Shares change (YoY)	-6.54%
Shares held by insiders	2.63%
Shares held by institutions	95.6%
Short ratio	11.7 days

Metric

Value

Float

213.6M

Shares change (QoQ)

-2.86%

Shares change (YoY)

-6.54%

Shares held by insiders

2.63%

Shares held by institutions

95.6%

Short ratio

11.7 days

BVMF/E2XE34 (BVMF/E2XE34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/E2XE34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/E2XE34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/E2XE34

Frequently asked questions